BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33109851)

  • 1. IDH1-R132H Suppresses Glioblastoma Malignancy through FAT1-ROS-HIF-1α Signaling.
    Li LC; Zhang M; Feng YK; Wang XJ
    Neurol India; 2020; 68(5):1050-1058. PubMed ID: 33109851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH1-R132H-FAT1-ROS-HIF-1α Signaling Pathway Inhibits Glioblastoma Tumor Progression.
    Kumar S; Banerjee J; Tripathi M; Chandra PS; Dixit AB
    Neurol India; 2020; 68(5):1059-1060. PubMed ID: 33109852
    [No Abstract]   [Full Text] [Related]  

  • 4. Propofol enhances the sensitivity of glioblastoma cells to temozolomide by inhibiting macrophage activation in tumor microenvironment to down-regulate HIF-1α expression.
    Zhao W; Yun K
    Exp Cell Res; 2022 Sep; 418(2):113277. PubMed ID: 35810776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
    Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
    Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic MicroRNA-20a is downregulated by the HIF-1α/c-MYC pathway in IDH1 R132H-mutant glioma.
    Xu Q; Ahmed AK; Zhu Y; Wang K; Lv S; Li Y; Jiang Y
    Biochem Biophys Res Commun; 2018 May; 499(4):882-888. PubMed ID: 29625108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis.
    Wang Q; Zhang L; Cui Y; Zhang C; Chen H; Gu J; Qian J; Luo C
    Oncol Rep; 2020 Jan; 43(1):188-200. PubMed ID: 31746408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical induction of HIF-1α expression by pericellular Notch1 signaling suffices for the malignancy of glioblastoma multiforme cells.
    Lee J; Kim E; Chong K; Ryu SW; Kim C; Choi K; Kim JH; Choi C
    Cell Mol Life Sci; 2022 Oct; 79(10):537. PubMed ID: 36183290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
    Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
    Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
    Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
    Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDH1
    Kim GH; Choi SY; Oh TI; Kan SY; Kang H; Lee S; Oh T; Ko HM; Lim JH
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R132H Mutation in IDH1 Gene is Associated with Increased Tumor HIF1-Alpha and Serum VEGF Levels in Primary Glioblastoma Multiforme.
    Yalaza C; Ak H; Cagli MS; Ozgiray E; Atay S; Aydin HH
    Ann Clin Lab Sci; 2017 May; 47(3):362-364. PubMed ID: 28667042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma.
    Srivastava C; Irshad K; Gupta Y; Sarkar C; Suri A; Chattopadhyay P; Sinha S; Chosdol K
    BMC Cancer; 2020 Jan; 20(1):62. PubMed ID: 31992226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide transcriptional analyses of Chinese patients reveal cell migration is attenuated in IDH1-mutant glioblastomas.
    Hu H; Wang Z; Liu Y; Zhang C; Li M; Zhang W; Wang K; Cai J; Cheng W; Huang H; Jiang T
    Cancer Lett; 2015 Feb; 357(2):566-74. PubMed ID: 25511738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults.
    Olar A; Raghunathan A; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Goodman JC; Fuller GN
    Ann Diagn Pathol; 2012 Jun; 16(3):161-70. PubMed ID: 22197544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression.
    Persano L; Pistollato F; Rampazzo E; Della Puppa A; Abbadi S; Frasson C; Volpin F; Indraccolo S; Scienza R; Basso G
    Cell Death Dis; 2012 Oct; 3(10):e412. PubMed ID: 23076220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma.
    Chen S; Wang Y; Xiong Y; Peng T; Lu M; Zhang L; Guo Z
    Int J Biol Sci; 2021; 17(5):1250-1262. PubMed ID: 33867843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.